Latest period
-$143M
YoY change
+5.8%
5Y CAGR
—
Peak year (FY2020)
$69M
Latest annual
-$140M
Free Cash Flow history chart for Tango Therapeutics (TNGX) from 2019 to 2025
Latest: -$140M
Free Cash Flow growth chart for Tango Therapeutics (TNGX) from 2019 to 2025
Latest: +5.8%
Free Cash Flow history table for Tango Therapeutics (TNGX) from 2019 to 2025
| FY2025 | -$140M | +5.8% | -$7.68M | ||
| FY2024 | -$132M | +10.7% | -$12.7M | ||
| FY2023 | -$120M | +2.3% | -$2.74M | ||
| FY2022 | -$117M | +90.3% | -$55.4M | ||
| FY2021 | -$61.4M | -189.0% | -$130M | ||
| FY2020 | $69M | -359.1% | +$95.6M | ||
| FY2019 | -$26.6M | — | — |
- FY2025-$140M+5.8%
- FY2024-$132M+10.7%
- FY2023-$120M+2.3%
- FY2022-$117M+90.3%
- FY2021-$61.4M-189.0%
- FY2020$69M-359.1%
- FY2019-$26.6M—
Free Cash Flow values are taken from Tango Therapeutics's reported cash flow statements (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
About Free Cash Flow at Tango Therapeutics (TNGX)
Free Cash Flow for Tango Therapeutics (TNGX): headline value -$143M · YoY +5.8%. Annual and quarterly series, chart, and tables are below.
Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .
2025's annual free cash flow for Tango Therapeutics (TNGX) came in at -$140M – grew 5.8% year-over-year.
Tango Therapeutics free cash flow plunged from $69M in 2020 to -$140M in 2025, a 302.9% drawdown.
The highest annual free cash flow of $69M was reported in 2020. The lowest in the available history was -$140M in 2025.
Tango Therapeutics Free Cash Flow by Year
Tango Therapeutics Free Cash Flow 2025: -$140M
Tango Therapeutics free cash flow in 2025 was -$140M, grew 5.8% from 2024. This figure represents the lowest annual value in the available history.
Tango Therapeutics Free Cash Flow 2024: -$132M
2024's free cash flow for Tango Therapeutics came in at -$132M, grew 10.7% from 2023.
Tango Therapeutics Free Cash Flow 2023: -$120M
Tango Therapeutics posted free cash flow of -$120M in 2023, edged up 2.3% from 2022.
Tango Therapeutics Free Cash Flow 2022: -$117M
In 2022, Tango Therapeutics reported free cash flow of -$117M, surged 90.3% from 2021.
Tango Therapeutics Free Cash Flow 2021: -$61.4M
Tango Therapeutics free cash flow in 2021 was -$61.4M.
See more financial history for Tango Therapeutics (TNGX).
Sector peers by Free Cash Flow
Healthcare peers of Tango Therapeutics (TNGX), ranked by their latest free cash flow
| $19.7B | |
| $17.8B | |
| $16.1B | |
| $12.4B | |
| $8.97B | |
| $8.1B | |
| $6.29B | |
| $4.52B |
- $19.7B
- $17.8B
- $16.1B
- $12.4B
- $8.97B
- $8.1B
- $4.52B
Frequently asked questions
Tango Therapeutics (TNGX) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation
How this company returns cash to shareholders — buybacks, dividends, and stock splits.